List of Excipients in API elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate
Detailed excipient profiles for elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate
Excipient focus: ALUMINUM OXIDE
elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate drug variants containing ALUMINUM OXIDE
elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate drug variants not containing ALUMINUM OXIDE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: CELLULOSE, MICROCRYSTALLINE
elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate drug variants containing CELLULOSE, MICROCRYSTALLINE
elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate drug variants not containing CELLULOSE, MICROCRYSTALLINE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: COLLOIDAL SILICON DIOXIDE
elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate drug variants containing COLLOIDAL SILICON DIOXIDE
Company | Ingredient | NDC |
---|---|---|
State of Florida DOH Central Pharmacy | elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate | 53808-0887 |
>Company | >Ingredient | >NDC |
elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate drug variants not containing COLLOIDAL SILICON DIOXIDE
Company | Ingredient | NDC |
---|---|---|
Gilead Sciences Inc | elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate | 61958-1201 |
Avera McKennan Hospital | elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate | 69189-1201 |
>Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate drug variants containing CROSCARMELLOSE SODIUM
elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate drug variants not containing CROSCARMELLOSE SODIUM
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 2
elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate drug variants containing FD&C BLUE NO. 2
elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate drug variants not containing FD&C BLUE NO. 2
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE YELLOW
elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate drug variants containing FERRIC OXIDE YELLOW
elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate drug variants not containing FERRIC OXIDE YELLOW
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: HYDROXYPROPYL CELLULOSE
elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate drug variants containing HYDROXYPROPYL CELLULOSE
elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate drug variants not containing HYDROXYPROPYL CELLULOSE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: LACTOSE MONOHYDRATE
elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate drug variants containing LACTOSE MONOHYDRATE
elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate drug variants not containing LACTOSE MONOHYDRATE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate drug variants containing MAGNESIUM STEARATE
elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate drug variants not containing MAGNESIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL
elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate drug variants containing POLYETHYLENE GLYCOL
Company | Ingredient | NDC |
---|---|---|
Gilead Sciences Inc | elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate | 61958-1201 |
Avera McKennan Hospital | elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate | 69189-1201 |
>Company | >Ingredient | >NDC |
elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate drug variants not containing POLYETHYLENE GLYCOL
Company | Ingredient | NDC |
---|---|---|
State of Florida DOH Central Pharmacy | elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate | 53808-0887 |
>Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 3350
elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate drug variants containing POLYETHYLENE GLYCOL 3350
Company | Ingredient | NDC |
---|---|---|
State of Florida DOH Central Pharmacy | elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate | 53808-0887 |
>Company | >Ingredient | >NDC |
elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate drug variants not containing POLYETHYLENE GLYCOL 3350
Company | Ingredient | NDC |
---|---|---|
Gilead Sciences Inc | elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate | 61958-1201 |
Avera McKennan Hospital | elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate | 69189-1201 |
>Company | >Ingredient | >NDC |
Excipient focus: POLYVINYL ALCOHOL
elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate drug variants containing POLYVINYL ALCOHOL
elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate drug variants not containing POLYVINYL ALCOHOL
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate drug variants containing SILICON DIOXIDE
Company | Ingredient | NDC |
---|---|---|
Gilead Sciences Inc | elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate | 61958-1201 |
Avera McKennan Hospital | elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate | 69189-1201 |
>Company | >Ingredient | >NDC |
elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate drug variants not containing SILICON DIOXIDE
Company | Ingredient | NDC |
---|---|---|
State of Florida DOH Central Pharmacy | elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate | 53808-0887 |
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM LAURYL SULFATE
elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate drug variants containing SODIUM LAURYL SULFATE
elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate drug variants not containing SODIUM LAURYL SULFATE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: TALC
elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate drug variants containing TALC
elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate drug variants not containing TALC
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate drug variants containing TITANIUM DIOXIDE
elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate drug variants not containing TITANIUM DIOXIDE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.